top of page
Web AI created golden gate bridge.jpg
image.png

Trident MedTech Strategies

Advisory & Operating Leadership for Transformation, Innovation, and Scale

OUR VISION

OUR MISSION

Trident MedTech Strategies provides the objective velocity and specialized expertise required to bridge the gap between investment thesis and global scale. Led by a former Global MedTech CEO, we partner with Investors, Boards and Executive Leadership to de-risk high-stakes transitions and accelerate business results.

SERVICES

SERVICES

Neutral graphical background that connotes the spirit of medical technology without being

1

Platform Strategy & Operational Velocity

  • Asset-Centric Operating Models: Transitioning legacy matrix organizations for speed, delayering, and empowering teams as required to compete in fast-moving markets.
     

  • Precision Portfolio Prioritization: Sharpening R&D focus toward target segments to maximize capital efficiency and return on invested capital.
     

  • S&OP & Commercial Excellence Diagnostics: Evaluating integrated sales, operations planning, and commercial functions post-merger to eliminate cross-functional misalignment, stabilize inventory forecasting, and recover market velocity.
     

  • Operational Excellence & Supply Chain Resiliency: Optimizing production readiness, procurement architecture, and lead-time agility to de-risk global operations against market volatility.

2

GTM & Commercial Transformation

  • Global Market Entry: Partnering with executive teams to prioritize global commercialization roadmaps, navigate clinical adoption, and accelerate entry for first-in-class technologies.
     

  • Capital Readiness & Strategic Positioning: Transforming high-potential, founder-led MedTech and digital health concepts into fundable, institutional-grade assets by refining investment narratives and structuring investor collaterals. 
     

  • Commercial Velocity & Precision Targeting: Accelerating top-line growth through high-resolution market intelligence including AI-driven prospecting.
     

  • Pricing & Profitability Optimization: Delivering positive pricing leverage and margin growth through market segmentation and value-based pricing models. 

3

Investment Advisory & Operating Leadership

  • Transaction & Underwriting Advisory: Partnering with sponsors during critical underwriting windows to provide rapid diligence that stress-tests growth theses and uncovers proprietary value levers.
     

  • Investment Sourcing & Thesis Presentation: Assisting sponsors with buyout sourcing, CIM evaluations, and authoring comprehensive investment theses regarding competitive moats and addressable market expansion.
     

  • Capital Allocation & Portfolio Strategy: Advising institutional investors and analysts on emerging healthcare sector trends, and strategic capital deployment.
     

  • Fractional & Portfolio Operating Leadership: Augmenting leadership as a fractional executive or interim CEO to institutionalize entities, accelerate EBITDA, or prepare the asset for a premium exit.

LEADERSHIP

LEADERSHIP

Christian Headshot_edited.jpg

CHRISTIAN O'CONNOR

FOUNDER &

MANAGING DIRECTOR

Christian is a global transformation strategist with a career defined by scaling innovation and delivering sustained financial performance. He founded Trident MedTech Strategies to share many decades of operating experience, allowing for consulting and fractional support where needed.  

Previously, Christian served as President and CEO of GE HealthCare's Surgery business, a ~$1B enterprise, where he and his team accelerated new product innovation, industry collaboration, international expansion, supply chain resiliency, and operational efficiency. Prior to that role, he was appointed to the company's Executive Director leadership band and held a series of global P&L positions. This included serving as President and General Manager for Diagnostic Imaging across Europe, the Middle East and Africa, a $2B+ equipment and service franchise. In this role, he engineered a broad organizational transformation that integrated cross-functional teams, accelerated digital growth, captured market share, and achieved significant improvements in cash performance and lifecycle value. Christian’s foundational leadership at GE HealthCare also included serving as Vice President and General Manager for Computed Tomography and Molecular Imaging across the US, Canada, and Europe, where he managed core high-acuity modalities. Pivoting this established enterprise scale into disruptive agility, he was recruited to scale the private equity-backed imaging platform, Spectrum Dynamics Medical. As Global Chief Marketing Officer and General Manager for North America, he modernized the brand, launched next-generation products, strengthened commercial infrastructure, and advanced clinical relevance to position the entity for a premium market valuation before returning to GE HealthCare's senior leadership ranks.

​​

Christian’s MedTech leadership experience extends across the full value chain, including early-stage R&D, product strategy, commercial execution, manufacturing, supply chain, and lifecycle management. Before entering healthcare, Christian served as a Nuclear Submarine Officer and Diver in the U.S. Navy, advancing to Lieutenant Commander. He led teams responsible for reactor technology, engineering, navigation and tactical operations, earning multiple commendations for leadership and mission performance.

​​

Christian holds a BS in Biomedical Engineering from Marquette University and an MS in Engineering Management from The Catholic University of America. He completed senior executive leadership development at GE’s Crotonville institute and holds certifications in Artificial Intelligence (AI) from the Massachusetts Institute of Technology (MIT) and in Nuclear Engineering from the U.S. Department of Energy. Having lived and led globally, he is currently based in the San Francisco Bay Area.​​

TEAM

OUR TEAM

Trident MedTech Strategies operates as a high-agility advisory firm. While Christian serves as the lead strategist and primary partner for every engagement, Trident maintains an elite network of contract industry experts, specialized engineers, and clinical advisors for scalable expertise. We don't believe in "one-size-fits-all" consulting. When a project requires deep-dive technical specialization, we activate our vetted network of industry veterans and subject matter experts. This model allows us to:
 

  • Assemble Mission-Specific Teams: We recruit and contract with world-class specialists tailored to the technical needs of your specific product or portfolio.
     

  • Maintain Objective Velocity: By utilizing a flexible expert network, we bypass the overhead of traditional firms, delivering senior-level execution with specialized speed.
     

  • Bridge Technical Gaps: Whether your project requires deep-dive regulatory support, AI engineering, or specific clinical validation, we activate the right expertise at the right time.

Vetting for Mission-Critical Success

Every network partner is hand-selected based on three core criteria:
 

  1. Direct Industry Experience: Partners must have served in leadership or senior technical roles within MedTech or related high-stakes sectors. 
     

  2. Operational Pedigree: We prioritize "doers" over "theorists". We seek professionals who have successfully launched products or managed complex operations. 
     

  3. ​​Systems Thinking: All collaborators must align with Trident’s disciplined, high-performance culture and systems-based approach to problem-solving.

The Trident Advantage

WHY US?

Beyond capacity, an engagement unlocks unbiased objectivity and specialized speed. We bypass the learning curve that slows down internal teams and generalist firms. While your teams manage daily complexity, we provide the external lens and executive expertise, bypassing hiring overhead, to unlock growth. Our insights come from experiences and best practices gathered from Fortune 50 and growth stage startups, not theoretical frameworks. 

RESULTS
Web page photo 4_edited.jpg

RESULTS AT A GLANCE

Private Equity & Transaction Advisory
 

  • Investment Sourcing & Thesis Presentation: Drove buyout sourcing and target evaluation for middle-market private equity sponsors, authoring and presenting comprehensive investment theses to investment committees to guide acquisition strategy, outline addressable market expansion, and identify durable competitive moats.
     

  • Investment Due Diligence: Evaluated high-growth targets for mega-cap and middle-market private equity sponsors including a prominent AI-driven operational software platform, a leading healthcare technical services provider, and an advanced medical device OEM, delivering critical strategic analysis to stress-test growth theses and validate competitive moats under tight investment timelines.
     

  • Value Creation Planning: Authored a comprehensive go-to-market (GTM) roadmap for a prospective private equity acquisition that was fully implemented by the acquirer, successfully validating the original strategic architecture and underwriting assumptions.
     

  • Investor Relations & Capital Allocation: Advised institutional investors and analysts on emerging MedTech market trends, structural competitive moats, and capital allocation frameworks within the diagnostic imaging sector, robotics, AI, clinical education and more. 

Corporate Strategy & Portfolio Operations
 

  • Capital Readiness & Institutional Positioning: Structured the commercial messaging, fundraising strategies, and investor collaterals for early-stage digital health and medical imaging platforms preparing for institutional capitalization. Synthesized complex technical and software assets into clear market-entry narratives, elevating founder-led concepts into institutional-grade investment targets.
     

  • S&OP & Commercial Excellence Diagnostics: Evaluated the integrated sales, operations planning, and commercial excellence functions of a major global health organization post-merger. Diagnosed core cross-functional misalignment and engineered a focused remediation plan to stabilize forecasting, optimize global supply chain workflows, and recover commercial velocity.
     

  • Portfolio Strategy: Developed a focused innovation strategy for a global MedTech leader, integrating AI-enabled technologies to address unmet clinical needs and maximize cross-portfolio commercial leverage.
     

  • Surgical Go-To-Market: Partnered with the executive team of a first-in-class intraoperative molecular imaging firm to define their global commercialization roadmap, prioritize market entry, and accelerate clinical adoption.
     

  • Organizational Design: Guided a multinational firm’s global expansion by designing matrix operating models and optimized governance structures to enhance decision-making speed and operational scale.

CONTACT

CONTACT
 

Have a question or want to discuss a project? Please fill in the following contact form and we'll get back to you promptly:

Back to Top

BACK TO TOP

© 2025 by Trident MedTech Strategies

  • LinkedIn
bottom of page